Intuitive Surgical, Inc. $ISRG Stock: Hyperion Asset Management Ltd Reduces Position

Key Points

• Hyperion Asset Management reduced its Intuitive Surgical position by 22% in the third quarter, selling 92,290 shares and retaining 327,039 shares valued at approximately $133 million.
• Despite Hyperion’s reduction, institutional ownership remains high at 83.64%, with several major investors—including Arrowstreet, Assenagon, Amundi, and Temasek— increasing their holdings.
• Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $498.83, although some firms have recently lowered their targets.

Hyperion Asset Management Ltd lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 22.0% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 327,039 shares of the medical equipment provider's stock after selling 92,290 shares during the period. Intuitive Surgical comprises approximately 3.6% of Hyperion Asset Management Ltd's holdings, making the stock its 12th biggest position. Hyperion Asset Management Ltd owned approximately 0.09% of Intuitive Surgical worth $132,984,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in ISRG. Bank of New York Mellon Corp purchased a new stake in Intuitive Surgical in the second quarter worth about $1,335,753,000. Arrowstreet Capital Limited Partnership raised its stake in shares of Intuitive Surgical by 95.3% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider's stock worth $970,635,000 after buying an additional 1,027,475 shares during the period. Assenagon Asset Management S.A. lifted its position in shares of Intuitive Surgical by 55.8% during the 3rd quarter. Assenagon Asset Management S.A. now owns 1,557,940 shares of the medical equipment provider's stock valued at $633,505,000 after buying an additional 558,099 shares in the last quarter. Amundi lifted its position in shares of Intuitive Surgical by 8.6% during the 1st quarter. Amundi now owns 2,428,356 shares of the medical equipment provider's stock valued at $1,119,448,000 after buying an additional 193,096 shares in the last quarter. Finally, Temasek Holdings Private Ltd lifted its position in shares of Intuitive Surgical by 416.4% during the 1st quarter. Temasek Holdings Private Ltd now owns 227,211 shares of the medical equipment provider's stock valued at $104,742,000 after buying an additional 183,211 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have commented on ISRG shares. KeyCorp restated an "overweight" rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. Truist Financial lowered their target price on shares of Intuitive Surgical from $580.00 to $510.00 and set a "buy" rating on the stock in a research note on Thursday, July 16th. Evercore set a $430.00 price target on Intuitive Surgical in a research note on Monday, July 6th. TD Cowen reissued a "buy" rating on shares of Intuitive Surgical in a report on Monday. Finally, JPMorgan Chase & Co. lowered their price objective on Intuitive Surgical from $550.00 to $450.00 and set an "overweight" rating on the stock in a research report on Friday, July 17th. One research analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $498.83.

Insider Activity

In other news, EVP Gary Loeb sold 400 shares of the stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the sale, the executive vice president directly owned 5,320 shares in the company, valued at approximately $2,016,280. This represents a 6.99% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy Ladd sold 400 shares of the company's stock in a transaction on Monday, August 10th. The shares were sold at an average price of $379.00, for a total value of $151,600.00. Following the completion of the transaction, the director directly owned 251 shares in the company, valued at $95,129. This trade represents a 61.44% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 12,370 shares of company stock valued at $4,891,989. 0.60% of the stock is currently owned by corporate insiders.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: TD Cowen maintained a Buy rating and a $485 price target, citing robust demand for robotic surgery and potential upside if results exceed conservative forecasts. TD Cowen maintains Buy rating
• Positive Sentiment: Intuitive Surgical’s recurring revenue from instruments, accessories, and service contracts continues to benefit from procedure growth. Second-quarter da Vinci 5 placements rose to 246 from 180 a year earlier, while procedures increased approximately 15%, supporting the long-term growth outlook. Bull case for Intuitive Surgical
• Positive Sentiment: Expanding operating leases—accounting for 54% of second-quarter da Vinci placements versus 49% a year earlier—reduces hospitals’ upfront costs and could accelerate system adoption. Intuitive Surgical leasing analysis
• Neutral Sentiment: Investors are awaiting third-quarter earnings after the market close. Consensus expectations call for roughly 15.6% year-over-year revenue growth, slower than the 22.9% growth reported in the comparable quarter last year, making procedure growth, da Vinci 5 adoption, and management guidance key catalysts. Intuitive Surgical Q3 earnings preview
• Negative Sentiment: Beginning in 2027, Intuitive Surgical plans to extend the useful life of certain instruments. The move could lower hospitals’ costs and broaden adoption, but it may reduce near-term revenue and profit per procedure. Why Intuitive Surgical is lowering instrument costs
• Negative Sentiment: Leasing supports sales growth but requires Intuitive Surgical to finance equipment before receiving its full lifetime returns, increasing capital intensity. The stock’s elevated valuation also leaves limited room for an earnings or guidance disappointment.

Intuitive Surgical Stock Performance

ISRG stock traded up $4.85 during mid-day trading on Tuesday, reaching $438.03. 958,024 shares of the stock traded hands, compared to its average volume of 2,402,424. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88. The stock has a market capitalization of $154.75 billion, a PE ratio of 50.15, a PEG ratio of 3.22 and a beta of 1.46. The business has a 50-day moving average price of $392.22 and a two-hundred day moving average price of $409.24.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company's primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.